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Objectives. We sought to determine, in a large series of patients
with right atrial isomerism, factors associated with mortality.
Background. Right atrial isomerism is associated with complex
congenital heart disease and high morbidity and mortality.
Method. All data from patients diagnosed with right atrial
isomerism between January 1970 and March 1996 were reviewed.
Results. A total of 91 consecutive patients (54 male) were
identified. Most patients (89%) presented within the first month
of life, 62% at birth. Cardiac abnormalities included common
atrioventricular (AV) valve (81%), ventricular hypoplasia or sin-
gle ventricle (73%), abnormal ventriculoarterial connections
(96%), pulmonary outflow tract obstruction (84%), anomalous
pulmonary venous drainage (87%) and pulmonary vein obstruc-
tion (30%). The overall mortality rate was 69%. No interventions
were planned or performed in 24%, 95% of whom died. The
mortality rate for patients requiring their first cardiovascular
operation in the neonatal period was 75% versus 51% for those
with later first operations (p < 0.05). The surgical mortality rate
for patients undergoing pulmonary vein repair was 95%. Overall
survival estimates were 71% at 1 month, 49% at 1 year and 35% at
5 years. Independent risk factors for decreased time to death
included the absence of pulmonary outflow obstruction (relative
risk [RR] 2.23, p < 0.03), presence of major AV valve anomaly
(RR 5.23, p < 0.03) and obstructed pulmonary veins (RR 5.43, p <
0.0001).
Conclusions. Right atrial isomerism continues to have an
associated high mortality despite surgical innovations. Manage-
ment of pulmonary vein obstruction remains a serious problem
and is associated with high mortality.
(J Am Coll Cardiol 1998;31:1120–6)
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Hearts demonstrating right atrial isomerism are usually asso-
ciated with complex congenital cardiac malformations (1–13).
Many of these patients also have abnormalities of the spleen—
usually, but not invariably, asplenia (2,6,14–16).
Patients with asplenia and complex congenital heart disease
were once considered inoperable; but over the most recent two
decades, there have been increasing reports (17–20) of surgical
successes in patients with right atrial isomerism undergoing
either a one-ventricle (Fontan) or biventricular repair. Such
reports document outcomes for those relatively few patients
undergoing operation but do not provide information about an
institutional experience or outcomes from all such patients
referred over a defined interval. We report patient outcomes
for an institutional experience with right atrial isomerism seen
over an era of evolving management strategies.
To determine factors associated with poor prognosis, we
undertook a retrospective review of all patients diagnosed with
right atrial isomerism at our pediatric center between January
1970 and March 1996.
Methods
Definitions and patient identification. How best to diag-
nose hearts associated with asplenia and right atrial isomerism
remains controversial. Such patients have visceroatrial hetero-
taxia and atrial appendages that each tend to resemble mor-
phologically right atrial appendages; most also have juxtaposi-
tion of the abdominal aorta and inferior vena cava. Many, but
not all, have congenital abnormalities of the spleen, usually
asplenia.
Radiologic diagnosis of right atrial isomerism may be
suspected on plain X-ray films of the chest and abdomen by
identifying the position of the liver, stomach and bronchial
pattern (21). Echocardiographic or angiographic demonstra-
tion of a juxtaposed relation between the aorta and inferior
vena cava and the morphology of the atrial appendages was
used to support the diagnosis (22,23). When surgical interven-
tions or autopsies made direct visual examination of the atrial
morphology possible, the diagnosis was further verified.
The diagnosis of a common atrium was made if the
interatrial septum was absent or if a very large secundum and
primum defect with only a vestigial septum were present (3).
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Hearts having only one identifiable pumping chamber with
virtually an absent interventricular septum were classified as
either single-ventricle or univentricular hearts of right ventric-
ular morphology, left ventricular morphology or indeterminate
type.
Single-outlet aorta refers to the ventriculoarterial connec-
tion in these patients with a single ventricle (single-outlet right,
left or indeterminate ventricle) who have pulmonary atresia.
For the purpose of the present study, patients who had all
four pulmonary veins draining individually to the left-sided
atrium were considered to have “normal” drainage. The
remainder were classified as having anomalous pulmonary
venous connections. However, it was recognized that in certain
cases of dextrocardia, the left-sided atrium may not be the
“correct” one into which the pulmonary veins must drain. The
diagnosis of pulmonary venous obstruction was based on
clinical, radiographic, echocardiographic and angiocardio-
graphic investigations (24–26). In addition, prostaglandin chal-
lenge (13) unmasked obstruction of total anomalous pulmo-
nary venous connections in some patients.
A prominent feature of right atrial isomerism, asplenia is
suggested by the presence of erythrocytic inclusion bodies on a
peripheral blood smear. Nevertheless, these Howell-Jolly bod-
ies may be transiently present in normal newborns as well as in
patients with megaloblastic hemolytic anemias, thalassemia
and leukemia (3). In this series the status of the spleen was
determined and confirmed by a combination of tests, including
blood smear for presence of Howell-Jolly bodies, abdominal
ultrasound, radionuclide spleen scan and autopsy findings.
Right atrial isomerism is often used synonymously with the
term asplenia. However, asplenia is not a constant feature of
right atrial isomerism, as demonstrated by the presence of a
spleen in five of our patients and by similar published reports
(2,5,14–16).
The databases of the Divisions of Cardiology and Cardio-
vascular Surgery and Department of Pathology of The Hospi-
tal for Sick Children in Toronto were reviewed for patients
with right atrial isomerism between January 1970 and March
1996; all eligible patients were included in the present report.
The variables analyzed to identify risk factors for mortality
included birth weight and length of gestation; patient age,
cyanosis and prostaglandin dependence at presentation; pres-
ence of cardiac lesions, including anomalous heart position,
common atrium, major atrioventricular (AV) valve anomaly,
pulmonary outflow obstruction, anomalous pulmonary venous
connections, obstruction of pulmonary venous connections and
aortic outflow obstruction; presence of extracardiac lesions;
age at first surgical intervention; and types of interventions
performed.
Data analysis. Results are presented as number (percent)
of patients or mean value 6 SD, as appropriate. Kaplan-Meier
estimates were used to plot survival curves. Wilcoxon and log
rank tests were used to test the effect of intervention on time
to death. The independent effects of demographic and ana-
tomic variables on survival were analyzed with Cox proportion-
ate hazards modeling using forward stepwise variable selec-
tion. Variables related to mortality in univariate analysis with
p , 0.10 were tested in stepwise selection, with model selection
entry criteria set at p , 0.05. A separate multivariate analysis
was performed to determine the independent effect of inter-
ventions. SAS version 6.04 software was used to perform all
statistical analyses.
Results
Patients. A total of 91 consecutive patients (54 male) were
identified with a diagnosis of right atrial isomerism between
January 1970 and March 1996. The mean birth weight was
3.0 6 0.6 kg (n 5 79, the number of patients for which the
particular datum was available) and the mean length of
gestation was 39 6 3 weeks (n 5 81).
The majority of the patients presented at birth (56 [62%] of
90), with 80 (89%) of 90 presenting within the first month of
life. Age at presentation ranged from newborn to 7.7 months.
Cyanosis was evident during the first 24 h of life in 58 (67%) of
87 patients. As well, 40 (51%) of 79 patients required prosta-
glandin infusion at presentation to maintain oxygen saturation.
Cardiac lesions. The cardiac position was levocardia in 56
(63%) of 89 patients and dextrocardia in 33 (37%) of 89. A
common atrium was identified in 76 (84%) of 91 patients. A
common AV valve was present in 74 (81%) of 91 patients, with
absent left connection in 7 (8%) of 91. Ventricular hypoplasia
or single ventricle was present in 66 (73%) of 90 patients.
Hypoplastic right ventricle was noted in 28 (31%) of 90
patients, hypoplastic left ventricle in 27 (30%) of 90 and a
single ventricle in 11 (12%) of 90.
The ventriculoarterial connection was abnormal in 87
(96%) of 91 patients, with double-outlet right ventricle in 29
(32%) of 91, ventriculoarterial discordance in 44 (48%) of 91,
single-outlet aorta in 11 (12%) of 91 and double-outlet left
ventricle in 3 (3%) of 91. Ventriculoarterial concordance was
present in 4 (4%) of 91 patients.
Pulmonary outflow tract obstruction was identified in 76
(84%) of 91 patients and included pulmonary atresia in 23
(25%) of 91.
The majority of the patients (80 [88%] of 91) had no
systemic outflow obstruction. However, aortic valve stenosis
was present in 1 patient, aortic atresia in 1, subaortic stenosis
in 5 (5%) of 91 and coarctation of the aorta in 4 (4%) of 91. A
right aortic arch was present in 43 (49%) of 87 patients.
Total anomalous pulmonary venous drainage was present in
77 (87%) of 89 patients, was supracardiac in 42 (47%) of 89,
cardiac in 19 (21%) of 89 and infradiaphragmatic in 11 (12%)
of 89. Mixed-type anomalous pulmonary venous drainage was
present in 5 (6%) of 89 patients. Pulmonary venous obstruc-
Abbreviations and Acronyms
AV 5 atrioventricular
CI 5 confidence interval
RR 5 relative risk
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tion, as demonstrated by a combination of clinical, radio-
graphic, echocardiographic and angiocardiographic investiga-
tions, was present in 25 (30%) of 84 patients.
Superior vena cava anomalies were present in 55 (64%) of
86 patients; 23 (27%) of 86 had a single left-superior vena cava;
22 (26%) of 86 had bilateral superior vena cavae without a
bridging innominate vein; and 10 (12%) of 86 had bilateral
superior vena cavae with a bridging innominate vein.
The inferior vena cava drained into the right-sided atrium
in 41 (52%) of 79 patients, into the left-sided atrium in 34
(43%) of 79 and into the midline of the atrium in 4 (5%) of 79.
The hepatic veins drained normally into the inferior vena
cava in 41 (62%) of 66 patients. Total anomalous hepatic
venous drainage was present in 19 (29%) of 66 patients in the
presence of a normal intrahepatic inferior vena cava. Partial
anomalous hepatic venous drainage was present in 6 (9%) of
66 patients. Of the 19 patients with total anomalous hepatic
venous drainage, 12 have died, and autopsies have confirmed
that these were indeed cases of right atrial isomerism.
The most common combination of cardiac anomalies (n 5
46, or 51%) comprised anomalous pulmonary venous drainage,
pulmonary outflow obstruction, common atrium, major AV
valve anomaly, single ventricle or ventricular hypoplasia, ab-
normal ventriculoarterial connection and no aortic outflow
obstruction.
Extracardiac lesions. A midline liver position on clinical
examination and X-ray film was present in 66 (77%) of 86
patients. The liver was right-sided in 13 (15%) of 86 patients
and left-sided in 7 (8%) of 86.
Most patients had asplenia, with the exception of four who
each had a single rudimentary spleen and one with multiple
splenuli.
Gastrointestinal anomalies were present in 29 (34%) of 86
patients, with the most common defect (16 [19%] of 86) being
malrotation of the bowel such that the position of the cecum
(and appendix) was variable but not in the usual right lower
quadrant. Other anomalies included tracheoesophageal fistula
with esophageal atresia in one patient, hiatus hernia in one,
duodenal web in one, annular pancreas in two and anal atresia
in three.
Genitourinary anomalies (hydronephrosis, horseshoe kid-
ney, bilateral polycystic kidneys, absence of one kidney or
cryptoorchidism) were present in 7 (9%) of 82 patients.
Mortality without surgical intervention. After assessment,
no cardiovascular surgical interventions were planned or per-
formed in 22 (24%) of 91 patients, 21 (95%) of whom died at
a median age of 4 days. Of these patients, 12 (with no notable
differences in complexity of cardiac lesions) were considered
inoperable by their attending cardiologist during the early part
of the study period. Of the other 10 patients, 5 had severe
noncardiac conditions (including disseminated cytomegalovi-
rus in 1); 2 died during initial operation for noncardiovascular
anomalies; 1 was diagnosed at autopsy after sudden infant
death syndrome; and 1 patient’s parents refused intervention.
One patient who presented recently is doing well and is
awaiting intervention.
Surgical interventions and mortality (Fig. 1). Cardiovas-
cular surgical interventions were performed in the majority of
patients (69 of 91).
Repair of anomalous pulmonary venous drainage was re-
quired at initial intervention in 20 patients, 14 with evidence of
pulmonary venous obstruction at the time of repair; there were
19 postoperative deaths (95%). Four patients had pulmonary
vein repair only (all died); 4 had concomitant pulmonary artery
banding (3 died); and 12 had concomitant placement of a
systemic to pulmonary-artery shunt (all died). Causes of death
in the immediate postoperative period included pulmonary
Figure 1. Flowchart showing surgical interventions and deaths. CPS 5
cavopulmonary shunt; Bivent 5 biventricular; CVS 5 cardiovascular
surgery; PAB 5 pulmonary artery band; PVR 5 pulmonary vein
repair; S-P 5 systemic to pulmonary artery; transplant 5 heart
transplantation.
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vein obstruction with pulmonary edema in 12 and 1 patient
each with obstructed shunt, excessive pulmonary blood flow
with pulmonary vein obstruction, ventricular fibrillation, elec-
tromechanical dissociation, cerebral infarction, pericardial
tamponade and severe bradycardia with cardiac arrest after
endotracheal suctioning. The one survivor went on to undergo
creation of a cavopulmonary anastomosis, followed by a suc-
cessful Fontan procedure.
The initial intervention was placement of a systemic to
pulmonary artery shunt alone in 37 patients, 7 of whom died
immediately after operation (blocked shunt in 2, excessive
pulmonary blood flow and low cardiac output in 3, cerebral
infarction in 1, pulmonary embolus in 1). There were 3
additional late deaths because of blocked shunt (at 5 months
after operation), pneumococcal meningitis (7 months) and
pneumonia (12 months after). Of the 27 survivors, 6 are alive
with no further operation to date, and 2 have had successful
biventricular repair. The other 19 patients have had takedown
of shunt and creation of a cavopulmonary anastomosis; 3 of
these patients died of pulmonary artery thrombosis (1 imme-
diately after the operation, 1 of pneumococcal sepsis while
receiving antibiotic prophylaxis 1 year postoperatively, 1 over-
seas patient from unknown causes 1 year postoperatively). Of
the 16 survivors after cavopulmonary anastomosis, 5 are alive
with no further operation to date. The other 11 patients have
undergone the Fontan procedure; 3 of these patients died of
intraoperative right ventricular myocardial infarction, pro-
longed cardiopulmonary bypass with myocardial failure and
cerebral infarction, respectively.
Pulmonary artery banding alone was the initial intervention
in three patients, two of whom died postoperatively (one with
no clear cause, one from bleeding complications). The remain-
ing patient has since had successful biventricular repair.
Three patients had creation of a cavopulmonary anastomo-
sis as their initial intervention. Two of these patients are alive
with no further operation to date. The other patient developed
progressive congestive heart failure and survived heart trans-
plantation at 23 years of age.
Two patients underwent Fontan procedure with no previ-
ous interventions; one patient later died of protein-losing
enteropathy that developed after a pulmonary artery throm-
bosis in the immediate postoperative period.
Two patients with subaortic obstruction and aortic arch
hypoplasia died immediately after the Norwood procedure (1
of intraoperative complications, other postoperatively of low
cardiac output).
Another patient, who had nonconfluent pulmonary arteries
and bilateral patent ductus arteriosi, died of multiorgan failure
after primary heart transplantation at the age of 3 months.
The one remaining patient underwent biventricular repair
with no previous interventions. This patient died intraopera-
tively during repair of AV septal defect.
Postoperative management and mortality (Fig. 2). Man-
agement and outcomes were further analyzed to determine the
likelihood of successful completion of intended management
strategy after the initial surgical intervention. Of the 69
patients who had initial cardiovascular surgical interventions,
64 were deemed to be on a Fontan track, whereas 4 were
directed toward biventricular repair. Primary heart transplan-
tation was the initial strategy in the remaining patient (de-
scribed above).
Of the 64 patients on the Fontan track, 62 had varying
pre-Fontan palliations (described earlier), and 2 had a single-
stage Fontan procedure (1 of whom died later). The total
mortality rate with pre-Fontan palliation was 56% (36 patients
died), with 13 patients alive without further intervention to
date and 12 patients undergoing staged Fontan procedure (3
died). The remaining patient, described earlier, had heart
transplantation after pre-Fontan palliation.
Only four patients had cardiac anatomy suitable for biven-
tricular repair. One patient with an AV septal defect, including
foramen primum atrial septal defect, small ventricular septal
defect and left valve cleft underwent patch closure of the atrial
septal defect and suture closure of the ventricular septal defect
and the cleft in the left AV valve. The patient sustained an
intraoperative cardiac arrest and could not be weaned from
cardiopulmonary bypass. One patient had a large foramen
secundum atrial septal defect, ventriculoarterial discordance
with intact ventricular septum and unobstructed total anoma-
lous pulmonary venous drainage to a confluence behind the
left atrium, draining through the vertical vein to the right
superior vena cava. This patient underwent pulmonary artery
banding at 1 year, followed by an arterial switch operation and
anomalous pulmonary vein repair 4 months later. This patient
is currently alive at 3.3 years of age. Two other patients
underwent a Rastelli repair for double-outlet right ventricle
with pulmonary outflow tract obstruction; both are currently
alive at 9.8 and 23 years of age, respectively.
Risk factors for mortality. Kaplan-Meier survival analysis
showed an overall survival rate of 71% (95% confidence
interval [CI] 62% to 81%) at 1 month, 49% (95% CI 38% to
59%) at 1 year and 35% (95% CI 25% to 45%) at 5 years (Fig.
3). Survival for patients presenting from 1990 onward was
significantly worse (Wilcoxon test, p 5 0.09; log rank test, p 5
0.03) than for those presenting earlier, with a survival rate of
68% at 1 month and 32% at 1 year in the more recent cohort.
Figure 2. Intended management strategy after initial surgical inter-
vention. *Three early postoperative deaths and one late death. Abbre-
viations as in Figure 1.
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Significant independent risk factors for time to death from
Cox proportionate hazards modeling are shown in Table 1 (see
Methods for variables analyzed to identify risk factors for
mortality).
Patients were classified into three groups according to their
requirement for and timing of cardiovascular surgical interven-
tion (Table 2): those for whom none was planned or per-
formed; those who required it during their neonatal period
(#4 weeks of age); and those who required their first surgical
intervention after the neonatal period. Kaplan-Meier survival
curves for these groups are shown in Figure 4.
The independent effect of intervention on time to death was
likewise explored with Cox proportionate hazards modeling.
Only the presence of pulmonary vein obstruction remained an
additional independent risk factor; differences in survival
between intervention groups remained statistically significant
when controlled in the regression model for pulmonary vein
obstruction. Relative to the group requiring cardiovascular
intervention after the neonatal period, the relative risk for the
nonintervention group was 5.57 (p , 0.0001); and for the
group requiring their first surgical intervention during the
neonatal period, 2.15 (p 5 0.02).
Discussion
To our knowledge, this is the largest single clinical series
reported in English to date cataloging the various cardiac and
extracardiac lesions, along with management and outcomes.
This analysis reviewed the clinical presentation and course of
91 consecutive patients presenting to this institution over the
past 26 years.
Cardiac anatomy and outcomes. Patients with right atrial
isomerism constitute a heterogeneous group with severe and
complex congenital heart disease and extracardiac anomalies.
Several clinical and necropsy series (1–3,6–12,27) have listed
the range of cardiac anomalies in this disorder, the frequencies
of which were similar to those noted here.
Influence of pulmonary vein anomalies. Patients with total
anomalous pulmonary venous drainage (present in 87% of our
patients, with 30% having obstructed pulmonary veins) had
uniformly poor outcomes, as reported elsewhere (28–30); the
surgical mortality rate in patients with pulmonary vein repair
was 95%. Jenkins et al. (31) have demonstrated that patients
with heterotaxy syndrome have a mean indexed pulmonary
vein sum significantly smaller than that of patients without
heterotaxy. They have also reported that pulmonary vein size is
a strong predictor of survival in patients with total anomalous
pulmonary venous connections. Although individual pulmo-
nary vein diameters were not routinely measured in our
patients, these factors may be an additional contributing factor
for the high mortality in this group of patients.
The large pooled autopsy series of asplenia cases reported
by Phoon and Neill (30), which approximates a natural history
study, found that the prognosis for total anomalous pulmonary
venous return is poor, with a median age of 3 months at death.
When both total anomalous pulmonary venous return and
pulmonary atresia were present, the median age at death
decreased to 1 month. Thus, it would seem that in this subset
of patients, surgical intervention does little to improve the
natural history.
Although all the patients in our series that had pulmonary
Figure 3. Kaplan-Meier survival estimates of overall survival of 91
patients with right atrial isomerism. The overall mortality rate was
69%. Dashed lines 5 95% CI.
Table 1. Independent Risk Factors for Mortality (Cox proportionate hazards modeling)*
Variable Beta-Coeff SE p Value RR (95% CI)
Absence of pulmonary
outflow obstruction
20.801 0.369 0.03 2.23 (1.08–4.59)
Presence of major AV
valve anomaly
1.654 0.728 0.03 5.23 (1.25–21.8)
Presence of obstructed
pulmonary veins
1.691 0.336 0.0001 5.43 (2.81–10.5)
*Final model based on n 5 84 observations with nonmissing values. AV 5 atrioventricular; CI 5 confidence interval;
Coeff 5 coefficient; RR 5 relative risk.








None (n 5 22) 5 (38%)† 95%
#4 wk old (n 5 32) 15 (47%) 75%
.4 wk old (n 5 39) 5 (13%) 51%
*Chi-square test. †This information was available for only 13 of the 20
patients in this group.
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vein repair with concomitant systemic to pulmonary shunts for
pulmonary outflow obstruction died, the independent risk
factor for decreased time to death was pulmonary vein obstruc-
tion. The additive risk of concomitant pulmonary outflow
obstruction could not be accurately assessed. However, ab-
sence of pulmonary outflow obstruction was an independent
risk factor for decreased time to death. One might speculate
that patients with a potential for excessive pulmonary blood
flow in conjunction with pulmonary vein obstruction may be at
higher risk for poor outcomes.
Influence of AV valve anatomy. A major AV valve anom-
aly, present in 89% of our patients, was found to be an
independent risk factor for increased mortality. Common AV
valve regurgitation has been reported to be more common in
patients with than in those without heterotaxy, with an accom-
panying greater need for AV valve surgery (32). Because
diagnostic modalities have changed during a study of this
length, accurate assessment of AV valve regurgitation out-
comes was not possible in the present cohort.
Surgical outcomes of Fontan procedure. The majority of
the patients (93%) were candidates for single-ventricle pallia-
tion. However, only 22% of these patients had completion of
their Fontan connection, with a surgical mortality rate of 21%.
Fifty-six percent of these patients with single-ventricle pallia-
tion died with palliation before a Fontan operation. The
remaining 20% of the patients on the single-ventricle track are
alive with palliation (i.e., pre-Fontan palliation). We speculate
that perhaps half of these patients may be suitable candidates
for a Fontan procedure. Thus, about one third of patients with
single-ventricle palliation may undergo the Fontan operation,
with a surgical mortality rate of 21%.
Recently, the Mayo Clinic reported their results for the
Fontan procedure (32). Patients with asplenia had a mortality
rate of 15% compared with an overall mortality of 9%.
Notably, the median age at time of operation in their Fontan
procedure cohort was 7 years, which may introduce a poten-
tially significant selection bias. However, it is encouraging that
mortality was dramatically lower than in their earlier (1973 to
1986) cohort (32), with a mortality rate for the asplenia group
of 61%.
Culbertson et al. (17) reported on surgical outcomes for 12
patients with asplenia who underwent the Fontan procedure.
The mortality rate in this group was 33%. They identified the
presence of important AV valve regurgitation, hypoplastic
pulmonary arteries and mean pulmonary artery pressures
.15 mm Hg after 6 months of age as factors that significantly
increased risks associated with the Fontan procedure.
Surgical outcomes of heart transplantation. Only two pa-
tients in our study underwent heart transplantation, with one
survivor. The Loma Linda group (33) has recently reported
their experience with heart transplantation in patients with
heterotaxy (20 with asplenia, 10 with polysplenia). They re-
ported a 5-year survival rate of 65%. Rates of rejection and
infection after transplantation were not different from those of
age-matched transplant recipients without heterotaxy. Addi-
tionally, they noted that asplenia was not an independent risk
factor for death.
Influence of age at initial intervention. Of our patients who
needed surgical intervention during the neonatal period, three
to four times as many had obstructed pulmonary veins as those
with later first operations. However, after controlling for the
presence of pulmonary vein obstruction, neonatal surgical
intervention remains a statistically significant risk factor for
poor outcome. This finding may suggest that patients who
require surgical intervention in the neonatal period have other
important adverse anatomic or physiologic risk factors.
Influence of sepsis. Three patients were identified as hav-
ing infection as the primary cause of death (already detailed).
However, because data on episodes of sepsis in the patients
were not always sufficient (especially in earlier records) or
available (many patients were likely to have been treated
elsewhere and not referred back to our cardiac center during
infectious illnesses), sepsis could not be accurately analyzed as
an independent risk factor for mortality.
Trends in outcomes. The retrospective nature of the
present study allowed a review of cases from a long interval
spanning 26 years. Despite the many advances in surgical
techniques and postoperative management of children with
congenital heart disease over this period, patients with right
atrial isomerism continue to have a very poor prognosis. In
fact, our data revealed that survival among patients presenting
from 1990 onward was significantly worse. Earlier diagnosis
and more aggressive management of high risk patients in the
recent years, as well as changes in the referral pattern of severe
congenital heart disease, may have influenced this increase in
the mortality rate. A selection bias may have occurred, such
that more children who survived the immediate postnatal
period (with the administration of prostaglandin infusions and
improved neonatal care and transport) and reached a diagnosis
were in the latter cohort. Indeed, the number of cases present-
Figure 4. Kaplan-Meier survival estimates for patients with right atrial
isomerism for whom no intervention was performed (95% mortality
rate), patients requiring their first surgical intervention during the
neonatal period (75% mortality rate) and patients requiring their first
surgical intervention after 4 weeks of age (51% mortality rate). The
differences in risk for the three groups of patients was significant at p 5
0.0001 (Wilcoxon and log rank tests).
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ing per year, the proportion of patients having surgical inter-
vention and the proportion of patients undergoing pulmonary
vein repair have all increased from 1990 onward. However,
these differences did not reach statistical significance.
Summary. Our institution’s 26-year experience with man-
agement of patients with right atrial isomerism highlights the
complexity of associated cardiac lesions reported in other,
smaller series. Independent risk factors for earlier mortality
include absence of pulmonary outflow obstruction, presence of
major AV valve anomaly and pulmonary vein obstruction.
Patients who require surgical intervention for obstructed pul-
monary veins or a combination of pulmonary vein repair and
augmentation of pulmonary blood flow by a systemic to
pulmonary shunt have an exceedingly high mortality.
Given the high mortality in this group of patients despite
recent innovations in congenital heart surgery, it seems pru-
dent to reassess conventional management strategies. Because
more centers are acquiring experience and expertise in neona-
tal and infant heart transplantation, this option will have to be
systematically evaluated as an alternative course of manage-
ment in selected patients; in other patients with multiple risk
factors for poor outcome, conservative management may be an
appropriate option.
This report was prepared with the assistance of Editorial Services, The Hospital
for Sick Children, Toronto, Ontario, Canada.
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